Revance
Biotechnology ResearchTennessee, United States501-1000 Employees
We are pleased to announce that Crown Laboratories and Revance Therapeutics are now united as REVANCE.
Market Position Revance operates in the rapidly expanding biotechnology and aesthetics sector with a strong focus on innovative skincare and sun protection products, making it an attractive partner or customer for advanced formulation, manufacturing, and distribution services.
Product Diversification The company's recent initiatives, including the launch and marketing of Blue Lizard mineral sunscreens and ongoing skincare treatments, present opportunities to explore complementary product development and licensing collaborations.
Growth Opportunities With a revenue range of 250 to 500 million and significant recent investments, Revance is poised for expansion, indicating a need for scalable manufacturing, technological upgrades, and distribution network enhancements.
Regulatory and Legal Environment Ongoing investigations and class action lawsuits suggest a focus on corporate governance and compliance services, offering avenues for legal consultancy, risk management, and reputation management solutions.
Digital Engagement Revance's active online presence, including digital marketing campaigns like billboard promotions for Blue Lizard, opens up possibilities for advertising, marketing technology, and digital content creation partnerships.
Revance uses 8 technology products and services including jsDelivr, Drupal, Module Federation, and more. Explore Revance's tech stack below.
| Revance Email Formats | Percentage |
| First.Last@revance.com | 55% |
| FLast@revance.com | 38% |
| FirstLast@revance.com | 5% |
| Last@revance.com | 2% |
Biotechnology ResearchTennessee, United States501-1000 Employees
We are pleased to announce that Crown Laboratories and Revance Therapeutics are now united as REVANCE.
Revance has raised a total of $100M of funding over 17 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $100M.
Revance's revenue is estimated to be in the range of $250M$500M
Revance has raised a total of $100M of funding over 17 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $100M.
Revance's revenue is estimated to be in the range of $250M$500M